Emorecha, Jayson L.

HRN: 29-11-06  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2026
CO-AMOXICLAV 625MG (TAB)
06/05/2026
06/12/2026
PO
625 MG/TAB
TID X 7 DAYS
LACERATED WOUND RIGHT FOREARM AND RIGHT ELBOW
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: